BNP Paribas Financial Markets
KITE

BNP Paribas Financial Markets’s Kite Pharma, Inc. KITE Stock Holding History

BNP Paribas Financial Markets’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-242,950
Closed -$43.7M – 4397
2017
Q3 		$43.7M Buy
242,950
+229,369
+1,689% +$32M 0.11% 165
2017
Q2 		$1.41M Sell
13,581
-13,911
-51% -$1.14M ﹤0.01% 1371
2017
Q1 		$2.16M Buy
27,492
+14,532
+112% +$899K 0.01% 1030
2016
Q4 		$581K Buy
12,960
+9,659
+293% +$474K ﹤0.01% 1615
2016
Q3 		$184K Buy
3,301
+1,768
+115% +$98.5K ﹤0.01% 1795
2016
Q2 		$76.7K Buy
+1,533
New +$75.3K ﹤0.01% 2188
2016
Q1 		– Sell
-5,990
Closed -$369K – 3414
2015
Q4 		$369K Sell
5,990
-118
-2% -$8.31K ﹤0.01% 1539
2015
Q3 		$340K Buy
6,108
+3,548
+139% +$223K ﹤0.01% 1593
2015
Q2 		$156K Buy
2,560
+2,335
+1,038% +$133K ﹤0.01% 1836
2015
Q1 		$13K Buy
+225
New +$15.1K ﹤0.01% 2604

BNP Paribas Financial Markets's KITE Position: Q4 2017 in Review

BNP Paribas Financial Markets sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 242,950 shares — an estimated $43.7M sold.

BNP Paribas Financial Markets first reported a position in KITE in Q1 2015 and held it in 10 quarters. The position peaked at $43.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • BNP Paribas Financial Markets reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 242,950 Kite Pharma, Inc. shares in Q4 2017, an estimated $43.7M.
  • BNP Paribas Financial Markets first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 10 quarters.
  • BNP Paribas Financial Markets's Kite Pharma, Inc. position peaked at $43.7M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2017, filed 1 Feb 2018.